复发/难治性多发性骨髓瘤,relapsed or refractory multiple myeloma英语短句,例句大全

复发/难治性多发性骨髓瘤,relapsed or refractory multiple myeloma
1)relapsed or refractory multiple myeloma复发/难治性多发性骨髓瘤
1.Objective:To evaluate the effects and toxicity of Bortezomib and Dexamethasone in treatment of relapsed or refractory multiple myeloma.研究目的:了解硼替佐米联合地塞米松对复发/难治性多发性骨髓瘤的疗效及不良反应。

英文短句/例句

1.Clinical Study of New Therapy for Relapsed/refractory Multiple Myeloma;复发/难治性多发性骨髓瘤新疗法的临床研究
2.The Effects of Bortezomib and Dexamethasone in the Treatment of Relapsed or Refractory Multiple Myeloma硼替佐米联合地塞米松治疗复发/难治性多发性骨髓瘤的临床疗效分析
3.Bortezomid in Combination with Chemotherapy in the Treatment of Relapsed or Refractory Multiple Myeloma;硼替佐米联合化疗治疗11例复发、难治性多发性骨髓瘤疗效观察
4.The Clinical Research on the CE-T Regimen in the Treatment of the Refractory and Recurrent Multiple Myeloma of the Aged PeopleCE-T方案治疗老年难治复发性多发性骨髓瘤的临床研究
5.Clinical observation of hydroxycamptothecin,cyclophosphamide,vincristine and methylprednisolone combination therapy for relapse,refractory and multiple myeloma羟基喜树碱联合方案治疗难治复发多发性骨髓瘤的临床观察
6.The clinical effects of thalidomide combined with VPD program therapy in refractory and relapsed multiple myeloma and the change of serum VEGF levels反应停联合VPD方案治疗难治及复发性多发性骨髓瘤疗效及VEGF水平变化
7.Nursing Care for Refractory Multiple Myeloma Cases Treated with Velcade and Dexamethasone万珂联合地塞米松治疗难治性多发性骨髓瘤患者的护理
8.Retrospective Analysis of 71 Cases of Multiple Myeloma71例初治多发性骨髓瘤的回顾性分析
9.Lenalidomide Plus Dexamethasone for Relapsed or Refractory Multiple Myeloma: Systemic Review来那度胺联合地塞米松治疗复发难治性骨髓瘤的系统评价
10.Cyclophosphamide thalidomide and dexamethasone combination chemotherapy in comparision with single-agent thalidomide in relapsed and refractory multiple myloma含沙利度胺的联合化疗方案与沙利度胺单药对复发难治多发性骨髓瘤的疗效比较
11.Clinical Observation of the Combination of Thalidomide and Dexamethasone for the Treatmemt of Recurrent Multiple Myeloma沙利度胺加地塞米松治疗复发性多发性骨髓瘤的临床观察
12.Clinical Study on Thalidomide in the Treatment of Multiple Myeloma;沙利度胺治疗多发性骨髓瘤临床研究
13.The Efficacy Observation of VAD Regimen in the Treatment of Multiple Myeloma;VAD方案治疗多发性骨髓瘤的疗效观察
14.A Study on the Treatment of Multiple Myeloma with VAD RegimenVAD方案用于多发性骨髓瘤治疗的研究
15.The study of thalidomide therapy in multiple myeloma:a report of 28 cases沙利度胺治疗多发性骨髓瘤28例分析
16.Treatment of multiple myeloma with VHEP regimen:a preliminary report of 16 casesVHEP方案治疗多发性骨髓瘤的初步报告
17.Efficacy of the combined therapy with bortezomib,dexamethasone and zoledronic acid in the treatment of multiple myelomaVDZ方案治疗多发性骨髓瘤疗效观察
18.Clinical Study of the Effect and Side-effects in Patients with Multiple Myeloma by the Treatment of T-VADT-VAD方案治疗多发性骨髓瘤临床研究

相关短句/例句

Multiple myeloma/therapy多发性骨髓瘤/治疗
3)multiple myeloma多发性骨髓瘤
1.An analysis of ocurrence and prognosis related factors of renal dysfunction in patients with multiple myeloma.;多发性骨髓瘤肾功能损害及预后相关因素研究
2.The influence of vascular endothelial growth factor on secretion of interleukin-6 of bone marrow stromal cells in multiple myeloma;VEGF对多发性骨髓瘤骨髓基质细胞分泌IL-6的影响
3.Effects of arsenic trioxide on the biological characteristics of multiple myeloma cell line RPMI8226;三氧化二砷对多发性骨髓瘤细胞生物学特性的影响
4)Multiple Myeloma(MM)多发性骨髓瘤
1.Objective:To investigate the application of immunoglobulin heavy chain(IgH) gene rearrangement in the diagnosis and therapy of multiple myeloma(MM).目的:探讨免疫球蛋白重链(IgH)基因重排在多发性骨髓瘤(MM)患者治疗过程中监测的临床意义。
2.Objective To explore whether there is any association between multiple myeloma(MM)and the infection of Borna disease virus(BDV).目的探讨Borna病病毒(BDV)感染与人类多发性骨髓瘤(MM)发病的关系。
3.Objective To estimate the prevalence of depression and anxiety in patients with multiple myeloma(MM)and to analyze the possible impact factors.目的评估多发性骨髓瘤(MM)患者伴抑郁、焦虑情绪的发生率,并分析其相关的影响因素。
5)MM多发性骨髓瘤
1.Detection and clinical significance of serumβ_2-MG、CRP level in MM;多发性骨髓瘤患者血清β_2-M、CRP水平的测定及临床意义
2.Objective: Aim Discussing the clinical characters,diagnosis,therapies,prognosis and some concerning factors of MM,discussing the reason of the error diagnosis,concluding the experience of the diagnosis and therapies.目的:探讨多发性骨髓瘤的临床特点、诊断、治疗及预后等相关因素,探讨误诊的原因,总结诊断和治疗的经验。
3.Methods Monocytic cells of bone marrow samples from 24 cases with acute lymphoblastic leukemia(ALL),15 cases with multiple myeloma(MM),26 cases with non-Hodgkins lymphoma(NHL),4 cases with chronic lymphocytic leukemia(CLL),4 cases with Hodgkins lymphoma(HD) and 16 healthy persons were measured by immunological fluores.方法　用免疫荧光方法检测 2 4例急性淋巴细胞白血病 (acutelymphoblasticleukemia ,ALL) ,15例多发性骨髓瘤 (multi plemyeloma ,MM) ,2 6例非霍杰金氏淋巴瘤 (non Hodgkinslymphoma ,NHL) ,4例慢性淋巴细胞白血病 (chroniclymphocyticleukemia ,CLL) ,4例霍杰金氏淋巴瘤 (Hodgkinslymphoma)及 16例正常人造血干细胞CD+ 3 4细胞表面CD5 4的表达。
6)multiple myeloma (MM)多发性骨髓瘤
1.Objective To determinate the concentrations of angiognic factors of bone marrow (BM) in multiple myeloma (MM) patients at different clinical stage,to analyze the relationships between angiogenesis and clinical status.目的测定不同临床阶段多发性骨髓瘤(MM)患者骨髓中血管新生因子的水平,分析其与疾病-临床分期之间的关系。
2.1dele ted in multiple myeloma (MM)patients,the expressed sequence ta gs(ESTs )which represent the novel gene in thi s region were obtained by bioinformatics analysis,then its expression was detected by semi-quantitative reverse tran-scription -polymerase chain reaction(RT-PCR).为克隆位于多发性骨髓瘤(multiplemyeloma,MM)患者染色体13q14。
3.Aim:To improve differential diagnosis by imaging(X-ray and CT) between multiple myeloma (MM) and metastatic tumor of bone.目的：为了提高对多发性骨髓瘤（ＭＭ）和骨转移瘤的影像学（Ｘ线、ＣＴ）的鉴别诊断水平。